Physician profile
James D Davis
NPI 1255313581
$2,038.09
in general payments reported to CMS, 2019-2025
18 companies · $566 in 2025
The $566 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $365 · 2020: $67.61 · 2021: $93.63 · 2023: $154 · 2024: $792 · 2025: $566.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,511.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,511.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $658.43 | 2019-2025 | Proclaim, Octrode, Eterna |
| Medtronic, INC. | $302.41 | 2024-2025 | Kyphon Express II Kyphopak Tray, Inceptiv, Intellis Adaptivestim |
| Stimwave Technologies Incorporated | $238.58 | 2019 | |
| Painteq LLC | $148.71 | 2024 | Painteq |
| Spr Therapeutics, INC | $134.55 | 2023 | Sprint Pns System |
| Si-Bone, INC. | $127.77 | 2024-2025 | |
| Curonix LLC | $97.95 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Vertex Pharmaceuticals Incorporated | $94.60 | 2024-2025 | |
| Azurity Pharmaceuticals, INC. | $33.97 | 2024-2025 | Horizant |
| Nevro Corp. | $33.52 | 2024 | Senza |
| Collegium Pharmaceutical, INC. | $28.87 | 2020-2021 | |
| Pfizer INC. | $26.45 | 2019-2020 | |
| Almatica Pharma LLC | $26.13 | 2021 | |
| Redhill Biopharma INC. | $21.11 | 2021 | |
| Spinal Simplicity, LLC | $19.23 | 2023 | Ha Minuteman G3-R |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalu Medical, INC. | $17.45 | 2024 | Nalu Neurostimulation System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.13 | 2025 | Relistor |
| Biodelivery Sciences International, INC. | $13.23 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.